Cargando…

New and old GFR equations: a European perspective

Glomerular filtration rate (GFR) is estimated in clinical practice from equations based on the serum concentration of endogenous biomarkers and demographic data. The 2009 creatinine-based Chronic Kidney Disease Epidemiology Collaboration equation (CKD-EPI(2009)) was recommended worldwide until 2021,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delanaye, Pierre, Cavalier, Etienne, Pottel, Hans, Stehlé, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	CKJ Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469124/ https://www.ncbi.nlm.nih.gov/pubmed/37664574 http://dx.doi.org/10.1093/ckj/sfad039

Ejemplares similares

Risk-based versus GFR threshold criteria for nephrology referral in chronic kidney disease
por: Oliva-Damaso, Nestor, et al.
Publicado: (2022)

Exploring Renal Function Assessment: Creatinine, Cystatin C, and Estimated Glomerular Filtration Rate Focused on the European Kidney Function Consortium Equation
por: Pottel, Hans, et al.
Publicado: (2024)

Comparison of Plasma Clearance With Early-Compartment Correction Equations and Urinary Clearance in High GFR Ranges
por: Delanaye, Pierre, et al.
Publicado: (2021)

Comparison of Early-Compartment Correction Equations for GFR Measurements
por: Delanaye, Pierre, et al.
Publicado: (2020)

Assessment of kidney function: clinical indications for measured GFR
por: Ebert, Natalie, et al.
Publicado: (2021)

Age and the eGFR-dependent risk for adverse clinical outcomes
por: Liu, Ping, et al.
Publicado: (2022)

Sodium–glucose cotransporter 2 inhibitors: renal outcomes according to baseline albuminuria
por: Delanaye, Pierre, et al.
Publicado: (2021)

Standardization of serum creatinine is essential for accurate use of unbiased estimated GFR equations: evidence from three cohorts matched on renal function
por: Pottel, Hans, et al.
Publicado: (2022)

The new Clinical Kidney Journal, 4 years later
por: Ortiz, Alberto, et al.
Publicado: (2019)

Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease
por: Donate-Correa, Javier, et al.
Publicado: (2022)

Creatinine-based GFR-estimating equations in children with overweight and obesity
por: van Dam, Mark J. C. M., et al.
Publicado: (2022)

A history of uraemic toxicity and of the European Uraemic Toxin Work Group (EUTox)
por: Vanholder, Raymond, et al.
Publicado: (2021)

Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA)
por: Sarafidis, Pantelis, et al.
Publicado: (2023)

A roadmap for optimizing chronic kidney disease patient care and patient-oriented research in the Eastern European nephrology community
por: Sever, Mehmet Şükrü, et al.
Publicado: (2020)

Iohexol Plasma Clearance: Impact of Weighing the Syringe
por: Delanaye, Pierre, et al.
Publicado: (2021)

Kidney involvement in multisystem inflammatory syndrome in children: a pediatric nephrologist’s perspective
por: Sethi, Sidharth Kumar, et al.
Publicado: (2021)

Citation classics: ranking of the top 100 most cited articles in nephrology
por: Montinaro, Vincenzo, et al.
Publicado: (2018)

Outcomes after kidney transplantation, let’s focus on the patients’ perspectives
por: Wang, Yiman, et al.
Publicado: (2021)

The membrane perspective of uraemic toxins: which ones should, or can, be removed?
por: Bowry, Sudhir K, et al.
Publicado: (2021)

Plant-based diets for CKD patients: fascinating, trendy, but feasible? A green nephrology perspective
por: Torreggiani, Massimo, et al.
Publicado: (2022)

Opportunities in the cloud or pie in the sky? Current status and future perspectives of telemedicine in nephrology
por: Stauss, Madelena, et al.
Publicado: (2020)

A new immune disease: systemic hypertension
por: Copur, Sidar, et al.
Publicado: (2023)

Artificial intelligence: a new field of knowledge for nephrologists?
por: Fayos De Arizón, Leonor, et al.
Publicado: (2023)

Novel non-cystic features of polycystic kidney disease: having new eyes or seeking new landscapes
por: Van Laecke, Steven, et al.
Publicado: (2020)

A brand-new cardiorenal syndrome in the COVID-19 setting
por: Apetrii, Mugurel, et al.
Publicado: (2020)

A new series of advanced-level research methods papers
por: Jager, Kitty J, et al.
Publicado: (2020)

New aspects in cardiorenal syndrome and HFpEF
por: Méndez, Ana Belén, et al.
Publicado: (2022)

PoCUS in nephrology: a new tool to improve our diagnostic skills
por: Romero-González, Gregorio, et al.
Publicado: (2022)

Primary hyperoxaluria type 1 in developing countries: novel challenges in a new therapeutic era
por: Soliman, Neveen A, et al.
Publicado: (2022)

Trimming the fat: is there a health economic case for the use of new lipid-lowering drugs in chronic kidney disease? A scoping review
por: Gallagher, Alexandra, et al.
Publicado: (2021)

Asymptomatic hyperuricaemia in chronic kidney disease: mechanisms and clinical implications
por: Anders, Hans-Joachim, et al.
Publicado: (2023)

Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients
por: Delanaye, Pierre, et al.
Publicado: (2014)

Gluconeogenesis in the kidney: in health and in chronic kidney disease
por: Dalga, Delal, et al.
Publicado: (2023)

The Authors Reply
por: Delanaye, Pierre, et al.
Publicado: (2020)

The complex interplay between kidney injury and inflammation
por: McWilliam, Stephen J, et al.
Publicado: (2020)

MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant?
por: Delanaye, Pierre, et al.
Publicado: (2010)

The effect of a ketogenic diet on weight loss in CKD: a randomized controlled trial in obese stage G1–3a CKD patients
por: Zoccali, Carmine, et al.
Publicado: (2023)

Precision medicine for the treatment of glomerulonephritis: a bold goal but not yet a transformative achievement
por: Glassock, Richard J
Publicado: (2021)

Shared decision making: a personal view from two kidney doctors and a patient
por: Hole, Barnaby, et al.
Publicado: (2023)

Oxalate nephropathy: a review
por: Rosenstock, Jordan L, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uvbn1hug32lnfl597uet9jiill